Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Caribou Biosciences Inc before investing.

In this article, we go over a few key elements for understanding Caribou Biosciences Inc’s stock price such as:

• Caribou Biosciences Inc’s current stock price and volume
• Why Caribou Biosciences Inc’s stock price changed recently
• Upgrades and downgrades for CRBU from analysts
• CRBU’s stock price momentum as measured by its relative strength

About Caribou Biosciences Inc (CRBU)

Before we jump into Caribou Biosciences Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It is engaged in developing transformative therapies for patients with devastating diseases. Its genome-editing platform, including its Cas12a chRDNA technology, enables precision to develop cell therapies that are armored to potentially improve antitumor activity. Its pipeline includes three clinical-stage allogeneic cell therapies from its chimeric antigen receptor (CAR)-T (CAR-T) cell platform targeting the treatment of hematologic malignancies. CB-010 is the lead product candidate from its allogeneic CAR-T cell therapy platform and is being evaluated in patients with relapsed or refractory B cell non-Hodgkin lymphoma (r/r B-NHL). Its second product candidate, CB-011, is being evaluated in patients with relapsed or refractory multiple myeloma (r/r MM) in the CaMMouflage phase I trial. CB-012 is its third product candidate.

Want to learn more about Caribou Biosciences Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Caribou Biosciences Inc.

Caribou Biosciences Inc’s Stock Price as of Market Close

As of March 26, 2024, 4:00 PM, CST, Caribou Biosciences Inc’s stock price was $5.06.

Caribou Biosciences Inc is down 4.35% from its previous closing price of $5.29.

During the last market session, Caribou Biosciences Inc’s stock traded between $5.20 and $5.62. Currently, there are 88.59 million shares of Caribou Biosciences Inc stock available for purchase.

Unfortunately, Caribou Biosciences Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Caribou Biosciences Inc Stock Price History

Caribou Biosciences Inc’s (CRBU) price is currently down 36.03% so far this month.

During the month of March, Caribou Biosciences Inc’s stock price has reached a high of $8.22 and a low of $4.99.

Over the last year, Caribou Biosciences Inc has hit prices as high as $8.59 and as low as $3.44. Year to date, Caribou Biosciences Inc’s stock is down 19.43%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Caribou Biosciences Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 25, 2024, there were 2 analysts who downgraded Caribou Biosciences Inc’s stock and 3 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Caribou Biosciences Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Caribou Biosciences Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Caribou Biosciences Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Caribou Biosciences Inc (CRBU) by visiting AAII Stock Evaluator.

Relative Price Strength of Caribou Biosciences Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 25, 2024, Caribou Biosciences Inc has a weighted four-quarter relative price strength of -5.62%, which translates to a Momentum Score of 51 and is considered to be Average.

Want to learn more about how Caribou Biosciences Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Caribou Biosciences Inc Stock Price: Bottom Line

As of March 26, 2024, Caribou Biosciences Inc’s stock price is $5.06, which is down 4.35% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Caribou Biosciences Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.